His financial disclosures include receiving consulting, speaking, teaching, and/or advisory fees from Janssen, Aptalis, and AbbVie.
Conference Coverage
DDW: HBV, tuberculosis reactivations rare in IBD patients on biologic therapy
Publish date: May 18, 2015
AT DDW 2015